Laurie Burlingame

Lecturer


JD, Harvard Law School
MBA, Clark University
MA, Harvard University
BA, Wellesley College


Biography

Laurie Burlingame is a Member of the Corporate Practice Group at Morse, Barnes-Brown & Pendleton, PC. She counsels clients across the life sciences and technology industries in a wide range of transactional matters, including venture capital and debt financings, mergers and acquisitions, licensing and strategic collaborations, supply and manufacturing arrangements and capital market transactions. Laurie also serves as trusted outside general counsel to emerging and established private and public companies. In such role, she advises management teams and boards of directors on numerous matters across the corporate lifecycle, including formation and founder issues, corporate governance, structuring matters, research and commercial contracting, and disclosure obligations.

Laurie’s clients include pharmaceutical, medical device, diagnostics, biological materials and tools, AI, and other technology companies. She also represents venture capital firms and hedge funds in connection with their portfolio investments.

Active in the community, Laurie serves as a Lecturer at Boston University School of Law and serves on the boards of directors of Families for Depression Awareness and Girls Inc. of Boston and Lynn. She is also a frequent mentor and speaker for university and incubator programs and maintains active membership in local technology and medical associations, including Women in Bio. Laurie has also received several awards for dedication to pro bono service.

Prior to joining Morse, Laurie was a partner in the corporate business and transactions group at Morgan Lewis & Bockius LLP. Before Morgan Lewis, Laurie was a partner in the technology and life sciences group at Goodwin Procter LLP.

Activities & Engagements

No upcoming activities or engagements.

Courses

LAW AM 701

Professional Responsibility for Intl LLMS

2 credits

This course offers an approach to the lawyer's responsibilities to clients, the profession, and the public. Topics addressed will be problems of disclosure, conflict of interest, advertising, adversary tactics, competence, attorney fees, and fiduciary duties. GRADING NOTICE: This course does not offer the CR/NC/H option.


FALL 2026: LAW AM 701 A1, Aug 31st to Dec 3rd 2026
Days Start End Credits Instructors Bldg Room
Tue 4:20 pm 6:20 pm 2 Laurie Burlingame
SPRG 2027: LAW AM 701 B1, Jan 11th to Apr 21st 2027
Days Start End Credits Instructors Bldg Room
Tue 4:20 pm 6:20 pm 2 Laurie Burlingame
LAW JD 812

Transaction Simulation: Pharma/Biotech Collaboration for Drug Development

3 credits

Practice Areas: Healthcare law, Intellectual Property and Strategy Transactions This course is one of the semester-long transaction simulations offered as part of the Transactional Law Program. Collaborative activity is essential to the biopharmaceutical industry due to the high costs and risks associated with drug development. In this course, students will learn how to read, draft, and negotiate collaboration agreements for new drug research, development and commercialization partnerships between biopharmaceutical companies. The course will begin with a brief introductory overview of (i) the biotechnology industry, with a focus on the importance of partnering for successful drug development and commercialization; and (ii) different forms of partnering agreements to develop a general understanding of the structure of such contracts. For the duration of the course, students will be assigned to teams to review, revise and negotiate the terms of a collaboration agreement for their clients, either a large pharmaceutical company or a smaller biotechnology company. Students will learn to think critically about whether certain provisions favor one party or the other, and ways to modify such elements through drafting changes. At the conclusion of the course, each team will be asked to present the key terms of the proposed collaboration agreement to their client's board of directors. Through regular out-of-class assignments, including substantial drafting assignments involving marking up term sheets, preparing issues lists, revising key sections of the collaboration agreement that will be negotiated and finalized by the student teams, and delivering board presentations, the course builds contract analysis, drafting, negotiation and strategic thinking skills students will need as they enter transactional law practice. The course also addresses various ethical issues that may arise in connection with these types of transactions and in transactional practice generally. The course grade will be based on individual participation, drafting assignments, and contributions to team efforts. Please note that no scientific background is necessary for this course as we will not be focusing on the scientific rationale for collaborations. CLASS SIZE: Limited to 12 students. PREREQUISITE: Contract Drafting is recommended, but not required. NOTES: This course counts toward the 6-credit Experiential Learning requirement and also satisfies the Transaction Simulation requirement of the Transactional Practice Concentration. GRADING NOTICE: This course does not offer the CR/NC/H option. ATTENDANCE REQUIREMENT: A student who fails to attend the first class or to obtain permission to be absent from either the instructor or the Registrar will be administratively dropped from the course. Students who are on the wait list are required to attend the first class to be considered for enrollment. Because the course involves regular in-class exercises, some of which are done in teams, a


SPRG 2027: LAW JD 812 A1, Jan 11th to Apr 21st 2027
Days Start End Credits Instructors Bldg Room
Mon 4:20 pm 6:20 pm 3 Laurie Burlingame
LAW AM 787

Transaction Sim: Forming/Financing a Start-up (LLM)

3 credits

This course is a semester-long transaction simulation offered exclusively for LLM in American Law Program and LLM in Intellectual Property Law students. The simulated transaction is the formation and initial financing of a privately- held company in the software industry. The course will expose LLM students to the principal issues involved in counseling U.S.-based entrepreneurs as to their emerging businesses, including choice of entity and entity formation, equity compensation for founders and employees, intellectual property protection of company assets, capital raising through preferred stock financing, and negotiation of financing-related contracts based on industry- standard models. Through in-class discussions, homework assignments and graded writing assignments, students will simulate the work of both junior and senior practicing attorneys who counsel start-ups and their founders and investors. Students will review sample agreements related to start-up businesses such as formation and financing documents, draft and revise such agreements and conduct negotiations for the financing of an emerging business. While the simulation is based on a start-up transaction, many of the principles and concepts will be applicable to a broader range of business deals. The course grade will be based on homework assignments, class participation and graded writing assignments. CLASS SIZE: Limited to 12 students. PREREQUISITE(S): Contracts and Corporations, unless otherwise waived by the instructor. Prior work experience in transactional business law is neither required nor expected. ATTENDANCE REQUIREMENT: A student who fails to attend the first class or to obtain permission to be absent from either the instructor or the Registrar, will be administratively dropped from the class. Students who are on the wait list are required to attend the first meeting to be considered for enrollment. GRADING NOTICE: This class will not offer the CR/NC/H option.


SPRG 2027: LAW AM 787 A1, Jan 11th to Apr 21st 2027
Days Start End Credits Instructors Bldg Room
Tue 6:30 pm 8:30 pm 3 Laurie Burlingame